(Q34032319)

30 July 2017

title

Barrett's esophagus: progression to adenocarcinoma and markers (English)

1 reference

30 July 2017

1 reference

1 reference

George Triadafilopoulos

5

object named as

George Triadafilopoulos

0 references

Laura J. Hardie

7

object named as

Laura J Hardie

0 references

author name string

Dianchun Fang

1

1 reference

30 July 2017

Kiron M Das

2

1 reference

30 July 2017

Weibiao Cao

3

1 reference

30 July 2017

Usha Malhotra

4

1 reference

30 July 2017

Robert M Najarian

6

1 reference

30 July 2017

Charles J Lightdale

8

1 reference

30 July 2017

Ian L P Beales

9

1 reference

30 July 2017

Valter Nilton Felix

10

1 reference

30 July 2017

Paul M Schneider

11

1 reference

30 July 2017

Andrew M Bellizzi

12

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 September 2011

1 reference

Annals of the New York Academy of Sciences

30 July 2017

published in

1 reference

30 July 2017

volume

1232

1 reference

30 July 2017

page(s)

210-229

1 reference

A peculiar internalization of claudins, tight junction-specific adhesion molecules, during the intercellular movement of epithelial cells

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Claudin expression in Barrett's esophagus and adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Transformation of benign Barrett's epithelium by repeated acid and bile exposure over 65 weeks: a novel in vitro model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Repeated exposure to acid and bile selectively induces colonic phenotype expression in a heterogeneous Barrett's epithelial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Isolation and sequencing of a novel tropomyosin isoform preferentially associated with colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

NOX enzymes and the biology of reactive oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Acid-induced p16 hypermethylation contributes to development of esophageal adenocarcinoma via activation of NADPH oxidase NOX5-S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

cAMP-response element-binding protein mediates acid-induced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

NADPH oxidase NOX5-S mediates acid-induced cyclooxygenase-2 expression via activation of NF-kappaB in Barrett's esophageal adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

A G protein-coupled receptor responsive to bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Evolution of neoplastic cell lineages in Barrett oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Modification of insulin-like growth factor 1 receptor, c-Src, and Bcl-XL protein expression during the progression of Barrett's neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

IGFBP-3 and IGFBP-10 (CYR61) up-regulation during the development of Barrett's oesophagus and associated oesophageal adenocarcinoma: potential biomarkers of disease risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

A population-based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Gain of allelic gene expression for IGF-II occurs frequently in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Probe-based confocal laser endomicroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Confocal laser endomicroscopy in Barrett's esophagus and endoscopically inapparent Barrett's neoplasia: a prospective, randomized, double-blind, controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Leukocyte telomere length predicts cancer risk in Barrett's esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

American Gastroenterological Association technical review on the role of the gastroenterologist in the management of esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Predictors of progression in Barrett's esophagus: current knowledge and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

p53--a Jack of all trades but master of none

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Prognostic value of p53 mutations in oesophageal adenocarcinoma: final results of a 15-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Flow cytometric DNA analysis and p53 protein expression show a good correlation with histologic findings in patients with Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

Aneuploidy and Overexpression of Ki67 and p53 as Markers for Neoplastic Progression in Barrett's Esophagus: A Case–Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2011.06053.X

10.1111/J.1749-6632.2011.06053.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference